Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Revenue

Ever Supreme Bio Technology had revenue of 220.99M TWD in the quarter ending June 30, 2025, with 23.85% growth. This brings the company's revenue in the last twelve months to 990.96M, up 20.33% year-over-year. In the year 2024, Ever Supreme Bio Technology had annual revenue of 933.81M with 23.13% growth.

• Revenue (ttm): 990.96M
• Revenue Growth: +20.33%
• P/S Ratio: 13.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	933.81M	175.42M	23.13%
Dec 31, 2023	758.39M	130.88M	20.86%
Dec 31, 2022	627.51M	188.67M	42.99%
Dec 31, 2021	438.84M	368.24M	521.61%
Dec 31, 2020	70.60M	59.78M	552.53%